Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment
of resistant cancers. Many immune-related adverse effects including neurological effects …

Effective hospital readmission risk prediction tools exist, but do not identify actionable items
that could be modified to reduce the risk of readmission. Polypharmacy has attracted …

The transition of care from hospital to home is susceptible to clinical errors and adverse drug
events. Despite this risk and the benefits of an interprofessional approach to patient care, …

Objectives: This study evaluates the impact of pain education group visits on patients with
chronic non-cancer pain (CNCP). The primary outcome of the study was to evaluate patients’ …

Objective: Unknown etiology Background: Trigger-point injection (TPI) therapy is an effective
modality for symptomatic treatment of myofascial pain. Serious adverse effects are rarely …

Researchers are extensively searching for modifiable risk factors including high-risk medications
such as anticoagulation to avoid rehospitalisation. The influence of oral anticoagulant …

Background and purpose There are many challenges associated with longitudinally
applying therapeutic knowledge in the pharmacy curriculum. This study investigated student …

Background and purpose Specializations within doctor of pharmacy (PharmD) programs
allow student pharmacists to advance their knowledge and expertise in a specific area of …

Purpose: Introduction: Ceftriaxone is a third-generation cephalosporin widely used in clinical
practice. Ceftriaxone induced hepatotoxicity is rare (< 3%) and usually manifests as mild …

Purpose: Drug shortages are anticipated to worsen with time as the Coronavirus Disease
2019 (COVID-19) pandemic continues. The aim of this study is to track drug shortages within …